Paul Campbell
Comptroller/Controller/Auditor bij VIATRIS INC.
Vermogen: 2 M $ op 29-02-2024
Profiel
Currently, Paul B.
Campbell holds the position of Chief Accounting Officer & Controller of Viatris, Inc.
Mr. Campbell previously held the position of Chief Accounting Officer, Interim CFO & Senior VP at Mylan NV.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
VIATRIS, INC.
0.01% | 05-03-2024 | 154 144 ( 0.01% ) | 2 M $ | 29-02-2024 |
Actieve functies van Paul Campbell
Bedrijven | Functie | Begin |
---|---|---|
VIATRIS INC. | Comptroller/Controller/Auditor | 16-11-2020 |
Eerdere bekende functies van Paul Campbell
Bedrijven | Functie | Einde |
---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director of Finance/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VIATRIS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |